Kalocsay Marian

Marian Kalocsay is a prominent scientist in the field of therapeutic sciences and proteomics. He holds the position of Assistant Professor at the Department of Experimental Radiation Oncology at the University of Texas MD Anderson Cancer Center. Prior to this, he served as an Instructor in Therapeutic Sciences and Director of Proteomics at Harvard Medical School from June 2017 to July 2022.15

Education and Training

Kalocsay earned his Ph.D. in Cell Biology from the LMU University of Munich and Max-Planck Institute of Biochemistry in 2009. He has undergone extensive postgraduate training, including research fellowships at Harvard Medical School focusing on mass spectrometry and chromatin biology.12

Research Interests

His research primarily revolves around proximity proteomics and advanced mass spectrometry techniques. Kalocsay's work aims to investigate the dynamics of signaling processes, particularly in the context of immune checkpoints, which are crucial for understanding how tumors interact with the immune system. His innovative approaches seek to elucidate ligand-specific immune signaling and differential phosphorylation in checkpoint signaling.12

Publications and Contributions

Kalocsay has contributed significantly to the scientific community, with numerous publications that explore various aspects of mass spectrometry and systems pharmacology. His work has garnered considerable recognition, reflected in his citation metrics on platforms like Google Scholar.36

Current Role

As of now, he continues to lead research initiatives at MD Anderson Cancer Center, where he focuses on cancer therapy innovations and drug target discoveries.4

For further professional insights, Kalocsay maintains a profile on LinkedIn under the username mariankalocsay, where he shares updates related to his work and research endeavors.5